Patrick Wood
Stock Analyst at Morgan Stanley
(3.03)
# 1,170
Out of 4,981 analysts
105
Total ratings
46.15%
Success rate
2.05%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $84 → $76 | $65.17 | +16.63% | 6 | Aug 28, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $84 → $80 | $77.69 | +2.97% | 5 | Aug 21, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $186.15 | +5.83% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $247.84 | +19.03% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $118.80 | +3.54% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $14.91 | -12.81% | 8 | Aug 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $78 → $74 | $77.50 | -4.51% | 7 | Jul 31, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $39.52 | +72.06% | 3 | Jul 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Equal-Weight | $75 → $81 | $75.07 | +7.91% | 9 | Jul 15, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $82 → $89 | $76.55 | +16.26% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $27 | $23.88 | +13.09% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $9.11 | -1.15% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $74.10 | +39.00% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $125 | $98.98 | +26.29% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $82.36 | -12.58% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $125.72 | +37.61% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $22 | $12.43 | +76.99% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $332.18 | -4.57% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $5.87 | +70.36% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $27.19 | +36.08% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $130.10 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Aug 28, 2025
Maintains: Equal-Weight
Price Target: $84 → $76
Current: $65.17
Upside: +16.63%
Alcon
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $77.69
Upside: +2.97%
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $186.15
Upside: +5.83%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $247.84
Upside: +19.03%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $118.80
Upside: +3.54%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $14.91
Upside: -12.81%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $78 → $74
Current: $77.50
Upside: -4.51%
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $39.52
Upside: +72.06%
Edwards Lifesciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $75.07
Upside: +7.91%
DexCom
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $76.55
Upside: +16.26%
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $23.88
Upside: +13.09%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $9.11
Upside: -1.15%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $74.10
Upside: +39.00%
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $98.98
Upside: +26.29%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $82.36
Upside: -12.58%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $125.72
Upside: +37.61%
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $12.43
Upside: +76.99%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $332.18
Upside: -4.57%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $5.87
Upside: +70.36%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $27.19
Upside: +36.08%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $130.10
Upside: -